Mackenzie Financial Corp Heron Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$2.3 - $6.29 $9,142 - $25,002	3,975 Added 7.32%	58,257 $163,000
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $680 - $1,461	147 Added 0.27%	54,282 $310,000
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $199,539 - $301,102	23,897 Added 79.03%	54,135 $494,000
Q3 2021 Nov 08, 2021	SELL	$10.13 - $15.0 $2,309 - $3,420	-228 Reduced 0.75%	30,238 $323,000
Q2 2021 Aug 11, 2021	BUY	$13.27 - $18.48 $80,150 - $111,619	6,040 Added 24.73%	30,466 $473,000
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $15,707 - $22,460	-1,084 Reduced 4.25%	24,426 $396,000
Q4 2020 Feb 10, 2021	BUY	$14.61 - $22.14 $241,795 - $366,417	16,550 Added 184.71%	25,510 $540,000
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $156,083 - $238,425	8,960 New	8,960 $211,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.